投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
5.0 %
年文章数
1031
作者需知
暂无数据
NCBI查询
偏重的研究方向
期刊简介
稿件收录要求
稿件收录要求
Published by Future-Drugs.
ISSN: 1476-0584.
The vaccine field has been transformed by the technological advances of the past decade. We are now beginning to visualize the future impact of vaccines, in terms of both healthcare and economics. Prophylactic vaccines continue to offer a revolution in quality of life, particularly among the populations of developing countries. Expansion of the field into the area of therapeutic vaccines is set to change radically the wider perception of vaccines in the healthcare and R&D communities. Rapid advances are anticipated with the prospect of therapeutic vaccines for the treatment of AIDS, cancer and other major diseases. There remain many challenges in the delivery of cost-effective, safe vaccines. Expert Review of Vaccines provides structured, informed commentary on the development and application of new vaccines and vaccine technologies, with all articles subject to rigorous peer-review.
The vaccine field has been transformed by the technological advances of the past decade. We are now beginning to visualize the future impact of vaccines, in terms of both healthcare and economics. Prophylactic vaccines continue to offer a revolution in quality of life, particularly among the populations of developing countries. Expansion of the field into the area of therapeutic vaccines is set to change radically the wider perception of vaccines in the healthcare and R&D communities. Rapid advances are anticipated with the prospect of therapeutic vaccines for the treatment of AIDS, cancer and other major diseases. There remain many challenges in the delivery of cost-effective, safe vaccines. Expert Review of Vaccines provides structured, informed commentary on the development and application of new vaccines and vaccine technologies, with all articles subject to rigorous peer-review.
